BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 16636098)

  • 1. Chronic obstructive pulmonary disease: linking outcomes and pathobiology of disease modification.
    Rennard SI
    Proc Am Thorac Soc; 2006 May; 3(3):276-80. PubMed ID: 16636098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Airway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysema.
    Turato G; Zuin R; Miniati M; Baraldo S; Rea F; Beghé B; Monti S; Formichi B; Boschetto P; Harari S; Papi A; Maestrelli P; Fabbri LM; Saetta M
    Am J Respir Crit Care Med; 2002 Jul; 166(1):105-10. PubMed ID: 12091179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modifying the course of chronic obstructive pulmonary disease: looking beyond the FEV1.
    Zuwallack RL; Nici L
    COPD; 2012 Dec; 9(6):637-48. PubMed ID: 22958136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of forced expiratory volume in 1 second decline in the assessment of chronic obstructive pulmonary disease progression.
    Wise RA
    Am J Med; 2006 Oct; 119(10 Suppl 1):4-11. PubMed ID: 16996894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Functional measurements of the peripheral airways in COPD].
    Garcia G; Perez T; Verbanck S
    Rev Mal Respir; 2012 Feb; 29(2):319-27. PubMed ID: 22405121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. It's about time--directing our attention toward modifying the course of COPD.
    Cazzola M; Hanania NA; Jones PW; Mahler DA; Make B; Ohar J; Rennard S
    Respir Med; 2008 Jun; 102 Suppl 1():S37-48. PubMed ID: 18582796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of COPD.
    Spurzem JR; Rennard SI
    Semin Respir Crit Care Med; 2005 Apr; 26(2):142-53. PubMed ID: 16088433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA; Donaldson GC
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of chronic obstructive pulmonary diseases in general clinics in terms of FEV1/FVC.
    Fukahori S; Matsuse H; Takamura N; Hirose H; Tsuchida T; Kawano T; Fukushima C; Mizuta Y; Kohno S
    Int J Clin Pract; 2009 Feb; 63(2):269-74. PubMed ID: 19196365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden--the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study.
    Danielsson P; Ólafsdóttir IS; Benediktsdóttir B; Gíslason T; Janson C
    Clin Respir J; 2012 Apr; 6(2):120-7. PubMed ID: 21651748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathomechanisms in chronic obstructive pulmonary disease (COPD)].
    Glaab T; Hohlfeld JM; Jörres RA; Krug N; Welte T
    Med Klin (Munich); 2006 Dec; 101(12):951-6. PubMed ID: 17171318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing and applying a stochastic dynamic population model for chronic obstructive pulmonary disease.
    Hoogendoorn M; Rutten-van Mölken MP; Hoogenveen RT; Al MJ; Feenstra TL
    Value Health; 2011 Dec; 14(8):1039-47. PubMed ID: 22152172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translating new understanding into better care for the patient with chronic obstructive pulmonary disease.
    Pierson DJ
    Respir Care; 2004 Jan; 49(1):99-109. PubMed ID: 14733626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up.
    Contoli M; Baraldo S; Marku B; Casolari P; Marwick JA; Turato G; Romagnoli M; Caramori G; Saetta M; Fabbri LM; Papi A
    J Allergy Clin Immunol; 2010 Apr; 125(4):830-7. PubMed ID: 20227753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease modification in chronic obstructive pulmonary disease.
    Anzueto A
    Clin Chest Med; 2007 Sep; 28(3):609-16,vii. PubMed ID: 17720047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes.
    Garcia-Aymerich J; Gómez FP; Benet M; Farrero E; Basagaña X; Gayete À; Paré C; Freixa X; Ferrer J; Ferrer A; Roca J; Gáldiz JB; Sauleda J; Monsó E; Gea J; Barberà JA; Agustí À; Antó JM;
    Thorax; 2011 May; 66(5):430-7. PubMed ID: 21177668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in elastic fibres in the small airways and alveoli in COPD.
    Black PN; Ching PS; Beaumont B; Ranasinghe S; Taylor G; Merrilees MJ
    Eur Respir J; 2008 May; 31(5):998-1004. PubMed ID: 18216063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality in COPD: Role of comorbidities.
    Sin DD; Anthonisen NR; Soriano JB; Agusti AG
    Eur Respir J; 2006 Dec; 28(6):1245-57. PubMed ID: 17138679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes and markers in the assessment of chronic obstructive pulmonary disease.
    Jones PW; Agusti AG
    Eur Respir J; 2006 Apr; 27(4):822-32. PubMed ID: 16585091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study.
    Garcia-Aymerich J; Lange P; Benet M; Schnohr P; Antó JM
    Am J Respir Crit Care Med; 2007 Mar; 175(5):458-63. PubMed ID: 17158282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.